Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
97,996,626
-
Number of holders
-
36
-
Total 13F shares, excl. options
-
18,353,420
-
Shares change
-
-704,583
-
Total reported value, excl. options
-
$40,193,707
-
Value change
-
-$2,084,056
-
Put/Call ratio
-
1218%
-
Number of buys
-
20
-
Number of sells
-
-12
-
Price
-
$2.19
Significant Holders of aTYR PHARMA INC - COMMON STOCK (ATYR) as of Q4 2022
44 filings reported holding ATYR - aTYR PHARMA INC - COMMON STOCK as of Q4 2022.
aTYR PHARMA INC - COMMON STOCK (ATYR) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18,353,420 shares
of 97,996,626 outstanding shares and own 19% of the company stock.
Largest 10 shareholders include FEDERATED HERMES, INC. (5,231,600 shares), FMR LLC (4,351,407 shares), Alyeska Investment Group, L.P. (1,378,747 shares), Tikvah Management LLC (1,350,833 shares), VR Adviser, LLC (1,171,436 shares), VANGUARD GROUP INC (1,140,126 shares), Walleye Capital LLC (750,000 shares), Telemetry Investments, L.L.C. (624,000 shares), CITIGROUP INC (428,460 shares), and BlackRock Inc. (268,946 shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.